Tony Blakely on PHARMAC

Keytruda is the latest potentially life-saving cancer drug to hit the headlines. Like Herceptine before it, there have been many stories in the media about cancer sufferers who would be saved if only PHARMAC would fund it. Some Oncologists are calling Keytruda a real game changer. And as with Herceptine, PHARMAC is resisting until there's solid evidence that the drug really does work - but some politicians are once again arguing it should be fast-tracked.